MGT CAPITAL INVESTMENTS, INC. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that MGT CAPITAL INVESTMENTS, INC. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2018 | Dec 31, 2018 | $2.03M | Apr 16, 2019 |
| FY2018 | Dec 31, 2017 | $3.13M | Apr 16, 2019 |
| FY2017 | Dec 31, 2016 | $313.0K | Apr 2, 2018 |
| FY2016 | Dec 31, 2015 | $104.0K | Apr 20, 2017 |
| FY2015 | Dec 31, 2014 | $94.0K | Apr 14, 2016 |
| FY2014 | Dec 31, 2013 | $396.0K | Apr 15, 2015 |
| FY2013 | Dec 31, 2012 | $409.0K | Mar 28, 2014 |
| FY2012 | Dec 31, 2011 | $536.0K | May 31, 2013 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $87.0K | Mar 17, 2026 |
| FY2025 | Dec 31, 2024 | $322.0K | Mar 17, 2026 |
| FY2024 | Dec 31, 2023 | $399.0K | Nov 10, 2025 |
| FY2023 | Dec 31, 2022 | $809.0K | Apr 16, 2024 |
| FY2022 | Dec 31, 2021 | $883.0K | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $1.43M | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | $450.0K | Apr 15, 2021 |
| FY2019 | Dec 31, 2018 | $2.03M | Mar 30, 2020 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $1.63M | Apr 2, 2018 |
| FY2017 | Dec 31, 2016 | $104.0K | Apr 2, 2018 |
| FY2016 | Dec 31, 2015 | $99.0K | Apr 20, 2017 |
| FY2015 | Dec 31, 2014 | $94.0K | Apr 14, 2016 |
| FY2014 | Dec 31, 2013 | ($163.0K) | Apr 15, 2015 |
| FY2013 | Dec 31, 2012 | $144.0K | Mar 28, 2014 |
| FY2012 | Dec 31, 2011 | $432.0K | May 31, 2013 |
| FY2011 | Dec 31, 2010 | $424.0K | Mar 1, 2012 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($219.0K) | Mar 17, 2026 |
| FY2025 | Dec 31, 2024 | $5.52M | Mar 17, 2026 |
| FY2024 | Dec 31, 2023 | ($6.13M) | Nov 10, 2025 |
| FY2023 | Dec 31, 2022 | ($5.98M) | Apr 16, 2024 |
| FY2022 | Dec 31, 2021 | ($1.54M) | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | ($3.89M) | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | ($8.78M) | Apr 15, 2021 |
| FY2019 | Dec 31, 2018 | ($23.28M) | Mar 30, 2020 |
| FY2017 | Dec 31, 2017 | ($50.43M) | Apr 2, 2018 |
| FY2017 | Dec 31, 2016 | ($24.52M) | Apr 2, 2018 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($797.0K) | Mar 17, 2026 |
| FY2025 | Dec 31, 2024 | ($1.12M) | Mar 17, 2026 |
| FY2024 | Dec 31, 2023 | ($1.43M) | Nov 10, 2025 |
| FY2023 | Dec 31, 2022 | ($2.49M) | Apr 16, 2024 |
| FY2022 | Dec 31, 2021 | ($1.79M) | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | ($2.88M) | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | ($7.50M) | Apr 15, 2021 |
| FY2019 | Dec 31, 2018 | ($23.92M) | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | ($21.61M) | Apr 16, 2019 |
| FY2017 | Dec 31, 2016 | ($20.24M) | Apr 2, 2018 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2019 | Dec 31, 2018 | $47.0K | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | $346.0K | Apr 16, 2019 |
| FY2017 | Dec 31, 2016 | $297.0K | Apr 2, 2018 |
| FY2015 | Dec 31, 2014 | $188.0K | Apr 14, 2016 |
| FY2014 | Dec 31, 2013 | $73.0K | Apr 15, 2015 |
| FY2013 | Dec 31, 2012 | $83.0K | Mar 28, 2014 |
| FY2012 | Dec 31, 2011 | $1.14M | May 31, 2013 |
| FY2011 | Dec 31, 2010 | $1.58M | Mar 1, 2012 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2014 | Dec 31, 2014 | $5.51M | Apr 15, 2015 |
| FY2014 | Dec 31, 2013 | $9.12M | Apr 15, 2015 |
| FY2013 | Dec 31, 2012 | $4.55M | Mar 28, 2014 |
| FY2012 | Dec 31, 2011 | $7.15M | May 31, 2013 |
| FY2011 | Dec 31, 2010 | $10.18M | Mar 1, 2012 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($991.0K) | Mar 17, 2026 |
| FY2025 | Dec 31, 2024 | ($547.0K) | Mar 17, 2026 |
| FY2024 | Dec 31, 2023 | ($710.0K) | Nov 10, 2025 |
| FY2023 | Dec 31, 2022 | ($2.15M) | Apr 16, 2024 |
| FY2022 | Dec 31, 2021 | ($1.16M) | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | ($650.0K) | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | ($3.96M) | Apr 15, 2021 |
| FY2019 | Dec 31, 2018 | ($8.76M) | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | ($2.38M) | Apr 16, 2019 |
| FY2017 | Dec 31, 2016 | ($5.53M) | Apr 2, 2018 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | May 13, 2025 | $1.35M | Mar 17, 2026 |
| FY2023 | Dec 31, 2022 | $68.0K | Apr 16, 2024 |
| FY2022 | Dec 31, 2021 | $212.0K | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $376.0K | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | $3.65M | Apr 15, 2021 |
| FY2019 | Dec 31, 2018 | $6.99M | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | $4.07M | Apr 16, 2019 |
| FY2017 | Dec 31, 2016 | $693.0K | Apr 2, 2018 |
| FY2016 | Dec 31, 2015 | $38.0K | Apr 20, 2017 |
| FY2014 | Dec 31, 2014 | $41.0K | Apr 15, 2015 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $106.0K | Mar 17, 2026 |
| FY2025 | Dec 31, 2024 | $764.0K | Mar 17, 2026 |
| FY2024 | Dec 31, 2023 | $932.0K | Nov 10, 2025 |
| FY2023 | Dec 31, 2022 | $1.65M | Apr 16, 2024 |
| FY2022 | Dec 31, 2021 | $2.87M | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $2.30M | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | $4.29M | Apr 15, 2021 |
| FY2019 | Dec 31, 2018 | $523.0K | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | $13.58M | Apr 16, 2019 |
| FY2017 | Dec 31, 2016 | $1.91M | Apr 2, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.39M | Mar 17, 2026 |
| FY2025 | Dec 31, 2024 | $3.25M | Mar 17, 2026 |
| FY2024 | Dec 31, 2023 | $9.79M | Nov 10, 2025 |
| FY2023 | Dec 31, 2022 | $5.39M | Apr 16, 2024 |
| FY2022 | Dec 31, 2021 | $1.74M | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $1.81M | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | $1.07M | Apr 15, 2021 |
| FY2019 | Dec 31, 2018 | $1.83M | Mar 30, 2020 |
| FY2017 | Dec 31, 2017 | $1.70M | Apr 2, 2018 |
| FY2017 | Dec 31, 2016 | $2.49M | Apr 2, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($2.28M) | Mar 17, 2026 |
| FY2025 | Dec 31, 2024 | ($2.49M) | Mar 17, 2026 |
| FY2025 | Dec 31, 2023 | ($8.86M) | Mar 17, 2026 |
| FY2024 | Dec 31, 2022 | ($3.73M) | Nov 10, 2025 |
| FY2023 | Dec 31, 2021 | $1.13M | Apr 16, 2024 |
| FY2022 | Dec 31, 2020 | $491.0K | Mar 31, 2023 |
| FY2021 | Dec 31, 2019 | $3.23M | Mar 31, 2022 |
| FY2020 | Dec 31, 2018 | ($1.31M) | Apr 15, 2021 |
| FY2019 | Dec 31, 2017 | $11.87M | Mar 30, 2020 |
| FY2017 | Dec 31, 2016 | ($561.0K) | Apr 2, 2018 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2016 | Dec 31, 2015 | $1.50M | Apr 20, 2017 |
| FY2015 | Dec 31, 2014 | $1.50M | Apr 14, 2016 |
| FY2015 | Dec 31, 2013 | $1.50M | Apr 14, 2016 |
| FY2014 | Dec 31, 2012 | $0 | Apr 15, 2015 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($426.74M) | Mar 17, 2026 |
| FY2025 | Dec 31, 2024 | ($426.52M) | Mar 17, 2026 |
| FY2024 | Dec 31, 2023 | ($432.04M) | Nov 10, 2025 |
| FY2023 | Dec 31, 2022 | ($425.91M) | Apr 16, 2024 |
| FY2022 | Dec 31, 2021 | ($419.93M) | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | ($418.39M) | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | ($414.50M) | Apr 15, 2021 |
| FY2019 | Dec 31, 2018 | ($404.72M) | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | ($378.90M) | Apr 16, 2019 |
| FY2017 | Dec 31, 2016 | ($328.47M) | Apr 2, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $103.0K | Mar 17, 2026 |
| FY2025 | Dec 31, 2024 | $6.0K | Mar 17, 2026 |
| FY2024 | Dec 31, 2023 | $8.0K | Nov 10, 2025 |
| FY2023 | Dec 31, 2022 | $538.0K | Apr 16, 2024 |
| FY2022 | Dec 31, 2021 | $1.23M | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $236.0K | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | $216.0K | Apr 15, 2021 |
| FY2019 | Dec 31, 2018 | $96.0K | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | $9.52M | Apr 16, 2019 |
| FY2018 | Dec 31, 2016 | $345.0K | Apr 16, 2019 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Mar 17, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Mar 17, 2026 |
| FY2024 | Dec 31, 2023 | 0 | Nov 10, 2025 |
| FY2023 | Dec 31, 2022 | 0 | Apr 16, 2024 |
| FY2022 | Dec 31, 2021 | 0 | Mar 31, 2023 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Mar 17, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Mar 17, 2026 |
| FY2024 | Dec 31, 2023 | 0 | Nov 10, 2025 |
| FY2023 | Dec 31, 2022 | 0 | Apr 16, 2024 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 4.64B | Mar 17, 2026 |
| FY2025 | Dec 31, 2024 | 2.49B | Mar 17, 2026 |
| FY2024 | Dec 31, 2023 | 849.17M | Nov 10, 2025 |
| FY2023 | Dec 31, 2022 | 703.77M | Apr 16, 2024 |
| FY2022 | Dec 31, 2021 | 606.97M | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | 506.78M | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | 413.70M | Apr 15, 2021 |
| FY2019 | Dec 31, 2018 | 111.08M | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | 58.96M | Apr 16, 2019 |
| FY2017 | Dec 31, 2016 | 28.72M | Apr 2, 2018 |